65 /100
HIGH RISK
Score updated May 30, 2026

HELP — Cybin D/B/A Helus Pharma Dilution Risk Tracker

Track HELP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HELP — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
95
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
25%
📉 Score Deterioration 50%
• Score rose 41 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔔 Track HELP — Get forecast alerts →

💹 Market Data

Market Cap$227.02M
Shares Outstanding49.89M
FloatN/A
Cash$149.6K
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 207.8% shares (2025Q4 vs prior)
81 institutional holders · 31.15M shares
#1 Point72 Asset Management, L.P. 4.43M shares
#2 ORBIMED ADVISORS LLC 3.84M shares
#3 VR ADVISER, LLC 3.84M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.62M
Days to Cover3.3
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track HELP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HELP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for HELP
📊 HELP FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HELP Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.